| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/31/2010 | CN101684163A Polysaccharide of gastrodia elata sulphated derivative and preparation method and antitumor application thereof |
| 03/31/2010 | CN101684159A Protein derivatives of human granzyme B, and use thereof in targeted therapy on adenocarcinoma |
| 03/31/2010 | CN101684158A Binding domain-immunoglobulin fusion proteins |
| 03/31/2010 | CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon |
| 03/31/2010 | CN101684135A Methyl furan nucleoside compound, preparing method and application thereof |
| 03/31/2010 | CN101684123A Preparation method of 2-formamido thienopyridine derivatives and medical uses |
| 03/31/2010 | CN101684121A New crystal form of pemetrexed diacid and method for preparing same |
| 03/31/2010 | CN101684119A 5,8-disubstituted-1,6-quinazoline-7-amidocarbonylation compound, preparing method, composite and application thereof |
| 03/31/2010 | CN101684115A 4-(5-((2-(4-morpholinyl-6-phenylamino group-1,3,5-triazine-2-base) hydrazono) methyl) furan-2-base) benzoic acid, preparing method and application thereof |
| 03/31/2010 | CN101684114A Novel toluylene compound and preparation method thereof |
| 03/31/2010 | CN101684100A Preparation method of dexrazoxane and pharmaceutical salts thereof |
| 03/31/2010 | CN101684099A Propionic acid derivative of substituted aromatic ring and aromatic heterocycle and preparation method and application thereof |
| 03/31/2010 | CN101684094A 3-substituted-1, 8-naphthalimide compound and synthesis method and medical application thereof |
| 03/31/2010 | CN101684091A cannabinoid receptor ligands |
| 03/31/2010 | CN101683523A Preparation method of prostatic cancer specific DC cell vaccine which is insensitive to TGF-belta |
| 03/31/2010 | CN101683519A Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof |
| 03/31/2010 | CN101683518A Application of FHL 1 in preparing medicament for treating tumour |
| 03/31/2010 | CN101683499A Cancer curing capsule |
| 03/31/2010 | CN101683445A Chinese medicament for controlling and treating various benign and malignant tumors |
| 03/31/2010 | CN101683439A Traditional Chinese medicine preparation for treating nasopharyngeal carcinoma |
| 03/31/2010 | CN101683414A Drug for treating cancers |
| 03/31/2010 | CN101683380A Method for preparing irrigating solution with anti-tumor function |
| 03/31/2010 | CN101683367A Method for preparing emulsified medicinal composition containing oleum fructus bruceae |
| 03/31/2010 | CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof |
| 03/31/2010 | CN101683359A Traditional Chinese medicine composition for treating tumours and preparation method thereof |
| 03/31/2010 | CN101683355A Composition comprising a survivin oligonucleotide and gemcitabine for the treatment of cancer |
| 03/31/2010 | CN101683350A Preparation method and application of galloyl glucose compounds |
| 03/31/2010 | CN101683346A Tirapazamine parenteral hydrous preparation and preparation method thereof |
| 03/31/2010 | CN101683345A Application of pyrazol and pyrimidone derivative in preparation of antitumor medicament |
| 03/31/2010 | CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 03/31/2010 | CN101683331A Application of alkannin derivant |
| 03/31/2010 | CN101683322A Method for preparing nano berberine hydrochloride liposome by supercritical carbon dioxide method |
| 03/31/2010 | CN101683321A Nelarabine parenteral solution and method for preparing same |
| 03/31/2010 | CN101683319A Tirapazamine parenteral hydrous preparation and preparation method thereof |
| 03/31/2010 | CN101683317A 缓释组合物 Sustained release composition |
| 03/31/2010 | CN100596298C 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof |
| 03/31/2010 | CN100596294C 4'-substituted benzyloxy-phenyl butadiene derivatives and preparation and uses thereof |
| 03/31/2010 | CN100596282C Liuweidihuang multiple vatimines and its preparing method |
| 03/30/2010 | US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it |
| 03/30/2010 | US7687651 Method for the preparation of trans-or cis-diammoniumdichlorodihydroxoplatinum(IV) and the use thereof in the production of pharmaceutical active substances |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors |
| 03/30/2010 | US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS) |
| 03/30/2010 | US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 03/30/2010 | US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders |
| 03/30/2010 | US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/30/2010 | US7687497 C10-substituted camptothecin analogs |
| 03/30/2010 | US7687496 11-(4S)-[2-(dimethylvinylsilanyl)-ethyl]-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, for example; anti-tumor agents; potent inhibitors of Topoisomerase I |
| 03/30/2010 | US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery |
| 03/30/2010 | US7687480 Phosphonate compounds |
| 03/30/2010 | US7687479 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 03/30/2010 | US7687266 Pluripotency determining factors and uses thereof |
| 03/30/2010 | CA2583437C Novel inhibitors of folic acid-dependent enzymes |
| 03/30/2010 | CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 03/30/2010 | CA2445395C Heterocyclic compound and antitumor agent comprising the same as effective component |
| 03/30/2010 | CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 03/30/2010 | CA2436667C Novel bioactive substance |
| 03/30/2010 | CA2420894C Thienopyrimidines |
| 03/30/2010 | CA2364705C Optically pure camptothecin analogues |
| 03/30/2010 | CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions |
| 03/30/2010 | CA2241604C Mesothelium antigen and methods and kits for targeting it |
| 03/30/2010 | CA2208780C Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747 |
| 03/30/2010 | CA2144223C Effector proteins of rapamycin |
| 03/25/2010 | WO2010033980A2 4-azaindole bisphosphonates |
| 03/25/2010 | WO2010033978A2 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES |
| 03/25/2010 | WO2010033958A1 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 03/25/2010 | WO2010033871A2 Compositions and methods targeting glutaminase |
| 03/25/2010 | WO2010033866A2 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 03/25/2010 | WO2010033862A2 Methods for treating cancer |
| 03/25/2010 | WO2010033686A1 Methods for improved cryo-chemotherapy tissue ablation |
| 03/25/2010 | WO2010033678A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 03/25/2010 | WO2010033580A2 Curcumin conjugates for treating and preventing cancers |
| 03/25/2010 | WO2010033509A2 14-hydroxy-docosahexaenoic acid compounds |
| 03/25/2010 | WO2010033426A2 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 03/25/2010 | WO2010033425A2 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 03/25/2010 | WO2010033424A2 Nutritional support of the immune system during anti-cancer treatment |
| 03/25/2010 | WO2010033196A2 Simplified one-pot synthesis of [18f]sfb for radiolabeling |
| 03/25/2010 | WO2010033074A1 Use of a tlr7 agonist for the treatment of cancer |
| 03/25/2010 | WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 03/25/2010 | WO2010033011A1 Rosamine derivatives as agents for the treatment of cancer |
| 03/25/2010 | WO2010032880A2 Prophylactic/therapeutic agent for cancer |
| 03/25/2010 | WO2010032764A1 Therapeutic/prophylactic agent for prostate cancer |
| 03/25/2010 | WO2010032704A1 Pharmaceutical preparation comprising micro-rna-143 derivative |
| 03/25/2010 | WO2010032696A1 Diagnosis method and therapeutic method for cancer |
| 03/25/2010 | WO2010032582A1 Therapeutic agent for adult t-cell leukemia |
| 03/25/2010 | WO2010032436A1 Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid |
| 03/25/2010 | WO2010032010A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 03/25/2010 | WO2010031828A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 03/25/2010 | WO2010031825A2 Methods and compositions for the treatment of cancer |
| 03/25/2010 | WO2010031816A1 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES |
| 03/25/2010 | WO2010031766A1 Pharmaceutical combination of 1-(2-tetrahydrofuryl)-5-fluorouracil and caffeic acid phenethyl ester for oral treating of tumors |
| 03/25/2010 | WO2010031749A1 Compositions and methods for detecting tlr3 |
| 03/25/2010 | WO2010031713A1 Substituted pyrrolidine-2-carboxamides |
| 03/25/2010 | WO2010031361A1 A composition with inhibition activity on pathological angiogenesis |
| 03/25/2010 | WO2010031266A1 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide |
| 03/25/2010 | WO2010031265A1 Pharmaceutical composition for the treatment of proliferative diseases |
| 03/25/2010 | WO2010031251A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 03/25/2010 | WO2010031185A1 Treating cancer stem cells using targeted cargo proteins |
| 03/25/2010 | WO2010031171A1 Iap bir domain binding compounds |
| 03/25/2010 | WO2010014595A3 Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders |